Telomir Pharmaceuticals, Inc. Common Stock (TELO)
NASDAQ·Healthcare·Biotechnology
$1.47
+3.17%
Mkt Cap $45.04M
Next Earnings
In 14 daysWed, May 13, 2026
EPS Estimate
-$0.07
1 analysts
Revenue Estimate
$1.50M
Last quarter: beat by +14.29% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$45.04M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.30